Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.837
+0.004 (0.42%)
At close: Sep 18, 2024, 4:00 PM
0.859
+0.022 (2.66%)
After-hours: Sep 18, 2024, 5:54 PM EDT

Sangamo Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for SGMO stock have an average target of 2.67, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 218.96% from the current stock price of 0.84.

Analyst Consensus: Buy
Target Low Average Median High
Price $1.00 $2.67 $2.00 $5.00
Change +19.46% +218.96% +138.92% +497.30%

Analyst Ratings

The average analyst rating for SGMO stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 111111
Buy 333300
Hold 333333
Sell 100000
Strong Sell 000000
Total 877744

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +497.30% Aug 22, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +497.30% Jul 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +497.30% Jul 24, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +497.30% May 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$3$5
Strong Buy Reiterates $3$5 +497.30% Mar 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
55.39M
from 176.23M
Decreased by -68.57%
Revenue Next Year
84.21M
from 55.39M
Increased by 52.02%
EPS This Year
-0.51
from -1.48
EPS Next Year
-0.23
from -0.51
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
102.43M118.19M110.70M111.30M176.23M55.39M84.21M100.28M
Revenue Growth
21.29%15.39%-6.34%0.54%58.34%-68.57%52.02%19.09%
EPS
-0.85-0.90-1.23-1.25-1.48-0.51-0.23-0.17
EPS Growth
--------
Forward PE
--------
No. Analysts -----10109
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 153.3M 212.1M 158.6M
Avg 55.4M 84.2M 100.3M
Low 980,000 19.6M 24.4M

Revenue Growth

Revenue Growth 20242025202620272028
High
-13.0%
282.9%
88.3%
Avg
-68.6%
52.0%
19.1%
Low
-99.4%
-64.6%
-71.0%

EPS Forecast

EPS 20242025202620272028
High 0.02 0.19 0.03
Avg -0.51 -0.23 -0.17
Low -0.70 -0.58 -0.56

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.